Home › Trial NCT07244978
Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
- Trial IDNCT07244978
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
- Enrollment49
- Start date2026-06-03
- ConditionsEsophageal Squamous Cell Carcinoma · Neoadjuvant Therapy
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.